Greenhouse Funds LLLP Has $101.30 Million Stock Holdings in HealthEquity, Inc. $HQY

Greenhouse Funds LLLP lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,068,921 shares of the company’s stock after purchasing an additional 157,106 shares during the quarter. HealthEquity accounts for about 3.7% of Greenhouse Funds LLLP’s portfolio, making the stock its 8th biggest position. Greenhouse Funds LLLP owned about 1.24% of HealthEquity worth $101,302,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Simplify Asset Management Inc. acquired a new stake in shares of HealthEquity during the third quarter worth $1,498,000. 12th Street Asset Management Company LLC boosted its stake in HealthEquity by 114.4% in the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after purchasing an additional 145,151 shares during the period. Bessemer Group Inc. boosted its stake in HealthEquity by 21.3% in the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock worth $33,108,000 after purchasing an additional 61,317 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in HealthEquity by 45.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after purchasing an additional 48,621 shares in the last quarter. Finally, GDS Wealth Management increased its holdings in HealthEquity by 15.7% during the 3rd quarter. GDS Wealth Management now owns 100,969 shares of the company’s stock worth $9,569,000 after purchasing an additional 13,682 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is currently owned by insiders.

HealthEquity Trading Up 0.1%

Shares of NASDAQ:HQY opened at $78.57 on Thursday. The company’s 50-day moving average price is $82.48 and its two-hundred day moving average price is $90.55. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $116.65. The stock has a market capitalization of $6.71 billion, a PE ratio of 36.04, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HQY. Barrington Research restated an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research report on Friday, January 9th. Citigroup restated an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Finally, BMO Capital Markets set a $85.00 price target on HealthEquity in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $112.00.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.